TGF-β- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C

Robert H Weiss, Al Ramirez

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background. Glomerulonephritis is characterized by the accumulation of extracellular matrix protein within the glomerulus. This process, when allowed to proceed unimpeded, leads to glomerulosclerosis and eventually to cessation of glomerular filtration. There is evidence that protein kinase C (PKC) activation plays an important role in mediating at least some of the effects of TGF-β in vascular smooth-muscle cells. The current study was undertaken to determine whether PKC activity is required for both TGF-β and angiotensin II (Ang II) to induce mesangial cell matrix protein secretion. Methods. PKC was inhibited by two separate methods, and [3H]thymidine incorporation was assessed in both the presence and the absence of PKC inhibition. Conditioned medium from cells stimulated with TGF-β or Ang II was collected and analysed for secreted matrix proteins and sulphated proteins by SDS-polyacrylamide gel electrophoresis and western blotting. Results. Twenty-four-hour incubation of rat mesangial cells with phorbol-12-myristate-13-acetate (PMA) reduced total PKC activity to basal levels. Both TGF-β and Ang II were mitogenic in mesangial cells, and chronic PMA pre-incubation inhibited this DNA synthesis. TGF-β-and Ang-II-induced sulphated protein secretion into conditioned medium was markedly attenuated in PKC-downregulated cells. Secretion of the specific matrix proteins laminin and fibronectin by mesangial cells stimulated with either TGF-β or Ang II was also diminished in PKC-downregulated cells and in cells pre-incubated with the specific PKC inhibitor, chelerythrine. There was no evidence of generalized cell toxicity or decreased non-specific protein synthesis caused by these PKC inhibitors. Conclusions. PKC is a key intermediary in the process by which TGF-β and Ang II cause DNA synthesis and mesangial cell matrix protein production. Thus, PKC inhibitors deserve further study as potential therapeutic agents for a variety of glomerular diseases.

Original languageEnglish (US)
Pages (from-to)2804-2813
Number of pages10
JournalNephrology Dialysis Transplantation
Volume13
Issue number11
DOIs
StatePublished - Nov 1998

Fingerprint

Angiotensin II
Protein Kinase C
Mesangial Cells
Proteins
Protein C Inhibitor
Protein Kinase Inhibitors
Conditioned Culture Medium
Acetates
Down-Regulation
Extracellular Matrix Proteins
DNA
Laminin
Glomerulonephritis
Vascular Smooth Muscle
Fibronectins
Thymidine
Smooth Muscle Myocytes
Polyacrylamide Gel Electrophoresis
Western Blotting

Keywords

  • Angiotensin
  • Mesangial cell
  • Phorbol
  • Protein kinase C
  • Proteoglycan
  • TGF-β

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

TGF-β- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C. / Weiss, Robert H; Ramirez, Al.

In: Nephrology Dialysis Transplantation, Vol. 13, No. 11, 11.1998, p. 2804-2813.

Research output: Contribution to journalArticle

@article{c8b5a22efad94011aa4dfac73dae622c,
title = "TGF-β- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C",
abstract = "Background. Glomerulonephritis is characterized by the accumulation of extracellular matrix protein within the glomerulus. This process, when allowed to proceed unimpeded, leads to glomerulosclerosis and eventually to cessation of glomerular filtration. There is evidence that protein kinase C (PKC) activation plays an important role in mediating at least some of the effects of TGF-β in vascular smooth-muscle cells. The current study was undertaken to determine whether PKC activity is required for both TGF-β and angiotensin II (Ang II) to induce mesangial cell matrix protein secretion. Methods. PKC was inhibited by two separate methods, and [3H]thymidine incorporation was assessed in both the presence and the absence of PKC inhibition. Conditioned medium from cells stimulated with TGF-β or Ang II was collected and analysed for secreted matrix proteins and sulphated proteins by SDS-polyacrylamide gel electrophoresis and western blotting. Results. Twenty-four-hour incubation of rat mesangial cells with phorbol-12-myristate-13-acetate (PMA) reduced total PKC activity to basal levels. Both TGF-β and Ang II were mitogenic in mesangial cells, and chronic PMA pre-incubation inhibited this DNA synthesis. TGF-β-and Ang-II-induced sulphated protein secretion into conditioned medium was markedly attenuated in PKC-downregulated cells. Secretion of the specific matrix proteins laminin and fibronectin by mesangial cells stimulated with either TGF-β or Ang II was also diminished in PKC-downregulated cells and in cells pre-incubated with the specific PKC inhibitor, chelerythrine. There was no evidence of generalized cell toxicity or decreased non-specific protein synthesis caused by these PKC inhibitors. Conclusions. PKC is a key intermediary in the process by which TGF-β and Ang II cause DNA synthesis and mesangial cell matrix protein production. Thus, PKC inhibitors deserve further study as potential therapeutic agents for a variety of glomerular diseases.",
keywords = "Angiotensin, Mesangial cell, Phorbol, Protein kinase C, Proteoglycan, TGF-β",
author = "Weiss, {Robert H} and Al Ramirez",
year = "1998",
month = "11",
doi = "10.1093/ndt/13.11.2804",
language = "English (US)",
volume = "13",
pages = "2804--2813",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - TGF-β- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C

AU - Weiss, Robert H

AU - Ramirez, Al

PY - 1998/11

Y1 - 1998/11

N2 - Background. Glomerulonephritis is characterized by the accumulation of extracellular matrix protein within the glomerulus. This process, when allowed to proceed unimpeded, leads to glomerulosclerosis and eventually to cessation of glomerular filtration. There is evidence that protein kinase C (PKC) activation plays an important role in mediating at least some of the effects of TGF-β in vascular smooth-muscle cells. The current study was undertaken to determine whether PKC activity is required for both TGF-β and angiotensin II (Ang II) to induce mesangial cell matrix protein secretion. Methods. PKC was inhibited by two separate methods, and [3H]thymidine incorporation was assessed in both the presence and the absence of PKC inhibition. Conditioned medium from cells stimulated with TGF-β or Ang II was collected and analysed for secreted matrix proteins and sulphated proteins by SDS-polyacrylamide gel electrophoresis and western blotting. Results. Twenty-four-hour incubation of rat mesangial cells with phorbol-12-myristate-13-acetate (PMA) reduced total PKC activity to basal levels. Both TGF-β and Ang II were mitogenic in mesangial cells, and chronic PMA pre-incubation inhibited this DNA synthesis. TGF-β-and Ang-II-induced sulphated protein secretion into conditioned medium was markedly attenuated in PKC-downregulated cells. Secretion of the specific matrix proteins laminin and fibronectin by mesangial cells stimulated with either TGF-β or Ang II was also diminished in PKC-downregulated cells and in cells pre-incubated with the specific PKC inhibitor, chelerythrine. There was no evidence of generalized cell toxicity or decreased non-specific protein synthesis caused by these PKC inhibitors. Conclusions. PKC is a key intermediary in the process by which TGF-β and Ang II cause DNA synthesis and mesangial cell matrix protein production. Thus, PKC inhibitors deserve further study as potential therapeutic agents for a variety of glomerular diseases.

AB - Background. Glomerulonephritis is characterized by the accumulation of extracellular matrix protein within the glomerulus. This process, when allowed to proceed unimpeded, leads to glomerulosclerosis and eventually to cessation of glomerular filtration. There is evidence that protein kinase C (PKC) activation plays an important role in mediating at least some of the effects of TGF-β in vascular smooth-muscle cells. The current study was undertaken to determine whether PKC activity is required for both TGF-β and angiotensin II (Ang II) to induce mesangial cell matrix protein secretion. Methods. PKC was inhibited by two separate methods, and [3H]thymidine incorporation was assessed in both the presence and the absence of PKC inhibition. Conditioned medium from cells stimulated with TGF-β or Ang II was collected and analysed for secreted matrix proteins and sulphated proteins by SDS-polyacrylamide gel electrophoresis and western blotting. Results. Twenty-four-hour incubation of rat mesangial cells with phorbol-12-myristate-13-acetate (PMA) reduced total PKC activity to basal levels. Both TGF-β and Ang II were mitogenic in mesangial cells, and chronic PMA pre-incubation inhibited this DNA synthesis. TGF-β-and Ang-II-induced sulphated protein secretion into conditioned medium was markedly attenuated in PKC-downregulated cells. Secretion of the specific matrix proteins laminin and fibronectin by mesangial cells stimulated with either TGF-β or Ang II was also diminished in PKC-downregulated cells and in cells pre-incubated with the specific PKC inhibitor, chelerythrine. There was no evidence of generalized cell toxicity or decreased non-specific protein synthesis caused by these PKC inhibitors. Conclusions. PKC is a key intermediary in the process by which TGF-β and Ang II cause DNA synthesis and mesangial cell matrix protein production. Thus, PKC inhibitors deserve further study as potential therapeutic agents for a variety of glomerular diseases.

KW - Angiotensin

KW - Mesangial cell

KW - Phorbol

KW - Protein kinase C

KW - Proteoglycan

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=0031726398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031726398&partnerID=8YFLogxK

U2 - 10.1093/ndt/13.11.2804

DO - 10.1093/ndt/13.11.2804

M3 - Article

C2 - 9829482

AN - SCOPUS:0031726398

VL - 13

SP - 2804

EP - 2813

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 11

ER -